Skip to Content

LCE 150 (Stalevo 150 37.5 mg / 200 mg / 150 mg)

Generic Name: carbidopa/entacapone/levodopa

Pill with imprint LCE 150 is Brown, Elliptical / Oval and has been identified as Stalevo 150 37.5 mg / 200 mg / 150 mg. It is supplied by Novartis Pharmaceuticals.

Stalevo 150 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Stalevo 150 37.5 mg / 200 mg / 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 150

Stalevo 150

Generic Name:
carbidopa/entacapone/levodopa
Imprint:
LCE 150
Strength:
37.5 mg / 200 mg / 150 mg
Color:
Brown
Size:
15.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals
Inactive Ingredients:
corn starch
croscarmellose sodium
glycerin
hypromelloses
magnesium stearate
mannitol
polysorbate 80
povidone
sucrose
ferric oxide red
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00781-5654 Sandoz Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide